Johanna Holldack, a Venture Partner of Aravis, has worked for more than 15 years in the pharmaceutical industry, where she held key positions in both startup and large pharma companies. During this time she held management and executive positions at Behringwerke, Chiron, MediGene and Borean Pharma.
Dr. Holldack built global high performance teams and organizations, which managed projects in oncology, immunology, cardiology and vaccines from early stage to regulatory approval. Several INDs have been filed under her management and several drugs have been approved in Europe, the US and Asia. She managed several exits, participated in a successful IPO and played a key role in M&A teams and in- and out-licensing activities.
Dr. Holldack has a Medical Degree and is a board certified pediatrician. She has been an assistant professor at the University of Essen, research fellow of the Deutsche Krebshilfe, and a research associate at Harvard Medical School.